Search

Search Constraints

You searched for: Author/Creator Laplaud, David

Search Results

1. A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica. Issue 10 (10th September 2021)

2. Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD. (9th February 2021)

3. CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016)

4. CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016)

5. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. (22nd May 2018)

6. Determinants of therapeutic lag in multiple sclerosis. (October 2021)

7. Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders. (September 2017)

8. Effector Memory–Expressing CD45RA (TEMRA) CD8+ T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor–Dependent Proinflammatory and Migratory Responses. Issue 12 (December 2022)

9. Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort. (27th July 2021)

10. Evaluation of efficacy and tolerability of first-line therapies in NMOSD. (14th April 2020)